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Abstract
Objective—Contrary to the hypothesis that the racial/ethnic disparity in prostate cancer has a
hormonal basis, we did not observe a difference in serum testosterone concentration between non-
Hispanic black and white men in the Third National Health and Nutrition Examination Survey
(NHANES III), although non-Hispanic black men had a higher estradiol level. Unexpectedly,
Mexican-American men had the highest testosterone level. Next, we evaluated whether the same
patterns are observed during adolescence, the time of prostate maturation.
Methods—We measured serum testosterone, estradiol, and sex hormone binding globulin
(SHBG) by immunoassay in 134 males aged 12–19 in NHANES III. Mean concentrations were
compared by race/ethnicity adjusting for age, Tanner stage, percent body fat, waist, physical
activity, tobacco smoke, and the other hormones.
Results—After multivariable adjustment, in the 12–15 year-old males, testosterone concentration
was lower in non-Hispanic blacks than whites (P=0.043), SHBG concentration did not
significantly differ between the two groups. Mexican-Americans had the highest testosterone
(versus non-Hispanic black: P=0.002) and lowest SHBG (versus non-Hispanic white: P=0.010;
versus non-Hispanic black: P=0.047) concentrations. Estradiol concentration was lower in non-
Hispanic blacks (P=0.11) and Mexican-Americans (P=0.033) compared with non-Hispanic whites.
After multivariable adjustment, in the 16–19 year-old males, testosterone, estradiol, and SHBG
concentrations did not differ between non-Hispanic blacks and whites. Mexican-Americans had
the highest testosterone concentration (versus non-Hispanic white: P=0.08), but did not differ from
Corresponding Author: David S. Lopez, Division of Epidemiology, Human Genetics and Environmental Sciences, University of
Texas- Houston School of Public Health, 1200 Herman Pressler, suite E-629, Houston, TX 77030, Phone: 713.500.6348, Fax:
713.500.9264 (fax), David.S.Lopez@uth.tmc.edu.
Disclosure of Potential Conflicts of Interest: The content is solely the responsibility of the authors and does not necessarily represent
the official views of the National Cancer Institute or the National Institutes of Health.
NIH Public Access
Author Manuscript
Cancer Causes Control. Author manuscript; available in PMC 2013 December 04.
Published in final edited form as:
Cancer Causes Control. 2013 April ; 24(4): . doi:10.1007/s10552-013-0154-8.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
the other groups on estradiol and SHBG concentrations. In both age groups, these patterns were
generally present, but less pronounced after adjusting for age and Tanner stage only.
Conclusion—In adolescent males, non-Hispanic blacks did not have a higher testosterone
concentration than non-Hispanic whites, and Mexican-Americans had the highest testosterone
concentration, patterns similar to adult males.
Keywords
testosterone; adolescence; race and ethnicity
Introduction
In the US, black men have the highest prostate cancer incidence (annual: 230.8 per 100,000
men) and mortality (54.9 per 100,000) rates and Hispanic men the lowest rates (126.7 and
18.5 per 100,000, respectively) when compared with white men (142.8 and 22.4 per
100,000, respectively) [1]. The disparity in these rates between blacks and whites has long
been thought to be explained, in part, by racial differences in circulating testosterone
concentration [2]. However, our prior findings in a nationally representative sample of US
men do not support this hypothesis: we observed that serum testosterone concentration was
not statistically significantly different between non-Hispanic black and non-Hispanic white
men when taking into account age, percent body fat, alcohol, smoking, and physical activity
[3]. Other studies also reported no statistically significant difference [4–13], including in
young and adolescent males [14–16], whereas others reported higher testosterone levels in
black compared with white men [17–19], including in young adult males (≥18 years) [20,
21]. Although testosterone levels did not differ, in our prior study we observed that non-
Hispanic black men had a higher estradiol concentration, especially in young and mid-
adulthood, than non-Hispanic white men [3]. Some studies in older adults [19], young adults
[5], and adolescents [14–16, 22] had similar findings, whereas other studies did not find
differences in estradiol level between black and white adult, young adult, and adolescent
males [8, 9, 18, 20, 21].
While the lower risk of prostate cancer in Hispanic men has not been attributed to racial/
ethnic variation in sex steroid hormones, we also previously found in NHANES III that
Mexican-American men had the highest testosterone level, but had an estradiol level similar
to non-Hispanic whites [3]. Other studies have reported that Hispanic men had a testosterone
level similar to white men [13, 17, 18] or a slightly lower level than in whites [11]. No
racial/ethnic differences in estradiol level were reported in the only other study that included
Hispanic men [18].
Because sex steroid hormones are necessary for pubertal development and sexual function,
we hypothesized that racial/ethnic variation in levels at the time of prostate maturation
could, in part, explain the variation in prostate cancer rates among black, white, and
Hispanic men, irrespective of variation or lack of variation in hormone levels by race/
ethnicity in adulthood. Therefore, we evaluated racial and ethnic differences in sex steroid
hormone and SHBG concentrations in adolescence (12–19 years old) in a US nationally
representative sample. Importantly, we were able to take into account age and stage of
puberty, but also body fatness, other factors that may differ by race/ethnicity and influence
hormone levels, and mutually for the other hormones.
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Methods
Study population
The National Center for Health Statistics conducted the Third National Health and Nutrition
Examination Survey (NHANES III), a cross-sectional study of the US civilian non-
institutionalized population aged two months or older, between 1988 and 1994. NHANES
III used a multistage, stratified and clustered probability sampling in which Mexican-
Americans, non-Hispanic blacks, the elderly and young children were oversampled to ensure
adequate samples sizes.
NHANES III had two phases (1988–1991 and 1991–1994) from which independent,
unbiased national estimates of health and nutrition can be calculated. Participants were
interviewed at home and asked detailed demographic and health-related questions.
Participants also underwent extensive physical and laboratory examinations in a mobile
examination center or at a home visit. Trained-personnel collected blood samples from
participants after an overnight fast under standardized conditions [23]. During the
examination a trained examiner measured the participants’ height, weight, waist
circumference, and skinfolds. Tanner staging (five stages each for genitalia and pubic hair)
was performed by a physician trained to use the standardized protocol on 8 to 18 year old
participants. For this analysis, we assigned 19 year olds the highest Tanner stage (V). We
estimated percent body fat from tricep and subscapular skinfold measurements, pubic hair
Tanner staging, and equations for white and black youth from Slaughter et al. [24]; we
applied the formula for white youth to Mexican-American youth. Physical activity was
assessed by questionnaire. Tobacco smoke exposure was assessed by urinary cotinine levels.
Stored serum volume was adequate for measuring hormones for 161 of the 278 12–19 year-
old males who participated in the morning session of Phase I. Details about the choice of
hormones, session, and phase have been reported previously [3]. We excluded participants
with missing hormone measurements (N=5), Tanner staging (N=18), or other covariates
(N=4) leaving 134 for this analysis. Of these, 33 were non-Hispanic black, 38 were non-
Hispanic white, and 63 were Mexican-American.
Measurement of serum sex steroid hormones
Serum concentrations of total testosterone, total estradiol, and sex hormone binding globulin
(SHBG) were measured by competitive electrochemiluminescence immunoassay. Assay
details including sensitivity and variability have been reported previously [3]. Free
testosterone and free estradiol concentrations were estimated from total testosterone and
total estradiol, respectively, SHBG, and albumin concentrations using mass action equations
[25, 26].
Statistical Analyses
The statistical analysis was performed using SUDAAN [27] as implemented in SAS version
9.2 (Cary, NC). Sampling weights were applied to take into account selection probabilities,
over-sampling, non-response, and differences between the sample and the US adolescent
male population. Because androgen levels rise steeply during adolescence, we dichotomized
the participants into two age groups: 12–15 years old (early adolescence) and 16–19 years
old (late adolescence). To normalize the hormone distributions, we transformed the
concentrations using the natural logarithm. Separately by age group, we compared whether
age-adjusted characteristics differed by race/ethnicity using regression modeling. We ran
linear regression models separately for the 12–15 year olds and the 16–19 year olds
adjusting for age as a continuous variable (to minimize any residual difference in age among
the three racial/ethnic groups within the two age groups), and Tanner stage (to minimize
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differences in when the racial/ethnic groups enter puberty) for genitalia (3 categories:
combined stages 1 and 2, 3 and 4 and 5) and pubic hair (same as genitalia). We also ran
multivariable models further adjusting for factors that differ by race/ethnicity and that may
influence hormone levels: percent body fat (continuous), waist circumference (continuous),
physical activity frequency (0–2 times/week and ≥3 times/week), and cotinine level
(continuous). In the multivariable models, we also mutually adjusted for total testosterone,
total estradiol, and SHBG because these hormones compete for binding to SHBG
(correlations: in 12–15 year olds, total testosterone and total estradiol = +0.66, total
testosterone and SHBG = −0.25, total estradiol and SHBG = −0.51, free testosterone and
free estradiol = +0.74; in the 16–19 year olds, total testosterone and total estradiol = +0.65,
total testosterone and SHBG = −0.04, total estradiol and SHBG = −0.30, free testosterone
and free estradiol = +0.78). In the multivariable models for free hormones, we mutually
adjusted free testosterone and free estradiol. All P-values were from two-sided tests.
The protocols for the conduct of NHANES III were approved by the Institutional Review
Board of the National Center for Health Statistics, US Centers for Disease Control and
Prevention. Informed consent was obtained from all participants. The assay of these stored
serum specimens for the measurement of concentrations of sex steroid hormones was
approved by the Institutional Review Boards at the Johns Hopkins Bloomberg School of
Public Health and the National Center for Health Statistics, US Centers for Disease Control
and Prevention.
Results
Mean age varied slightly among the three racial/ethnic groups in the 12–15 year old males,
and in the 16–19 year old males; thus, we adjusted the results in Table 1 for the residual
variation in age within each group. In the 12–15 year olds, non-Hispanic blacks were the
leanest and were more advanced in puberty, and non-Hispanic whites were the least
physically active and had the highest cotinine level. In the 16–19 year olds, non-Hispanic
blacks were the leanest, were more advanced in puberty, were the most physically active,
and had the lowest cotinine levels.
Table 2 shows geometric mean hormone concentrations adjusted for age and Tanner-stage
given the residual differences in age and the differences in Tanner stage among the racial/
ethnic groups within the younger and within the older adolescent strata. Total and free
testosterone and total and free estradiol were lower and SHBG higher in the 12–15 year olds
than in the 16–19 year olds.
In 12–15 year olds, none of the hormones was statistically significantly different between
any of the racial/ethnic groups, although several patterns were present (Table 2). Total and
free testosterone concentrations were lower in non-Hispanic blacks than in non-Hispanic
whites; Mexican-Americans had the highest concentrations (total testosterone versus non-
Hispanic white P=0.077). Total estradiol concentrations were similar between non-Hispanic
blacks and Mexican-Americans, but possibly higher in non-Hispanic whites. For free
estradiol, concentrations were highest in non-Hispanic whites, intermediate in Mexican-
Americans, and lowest in non-Hispanic blacks. SHBG was lowest in Mexican-Americans
but similar between non-Hispanic blacks and non-Hispanic whites.
In the 16–19 year olds, only one difference approached statistical significance: Mexican-
Americans had higher total testosterone than did non-Hispanic whites (P=0.053); non-
Hispanic blacks had an intermediate concentration (Table 2). The same pattern was present
for free testosterone. Total and free estradiol, and SHBG concentrations appeared to be
higher in non-Hispanic blacks compared with the other two groups.
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Table 3 shows the geometric mean hormone concentrations after adjusting for age and
Tanner stage, for factors that influence hormone levels, and mutually adjusting for the other
hormones (testosterone, estradiol, and SHBG mutually adjusted; and free testosterone and
free estradiol mutually adjusted).
In 12–15 year olds, the hormone patterns by race/ethnicity observed after this multivariable-
adjustment were generally similar to, but more pronounced than the patterns after only age
and Tanner stage adjustment. The more pronounced patterns for total and free testosterone
were, in part, explained by adjustment for percent body fat and waist circumference. Total
(P=0.043) and free (P=0.030) testosterone concentrations were lower in non-Hispanic blacks
than non-Hispanic whites. Mexican-Americans had the highest total and free testosterone
concentrations (Table 3); these differences were statistically significant when compared with
non-Hispanic blacks (total: P=0.002; free: P=0.005). Total and free estradiol concentrations
were similar between non-Hispanic blacks and Mexican-Americans, but higher in non-
Hispanic whites; the difference between Mexican-Americans and non-Hispanic whites in for
total estradiol concentration was statistically significant (P=0.033). SHBG was lowest in
Mexican-Americans (versus non-Hispanic white: P=0.010; versus non-Hispanic black:
P=0.047) and similar between non-Hispanic blacks and non-Hispanic whites.
In the 16–19 year olds, the hormone patterns by race/ethnicity after multivariable adjustment
were similar to those after age and Tanner stage adjustment, although the hormone
concentrations for Mexican-Americans were more extreme after multivariable adjustment.
Total and free testosterone did not statistically significantly differ between non-Hispanic
blacks and non-Hispanic whites (Table 3). Mexican-Americans possibly had higher total
(P=0.080) and free (P=0.080) testosterone concentration than non-Hispanic whites, but not
than non-Hispanic blacks. Total and free estradiol, and SHBG concentrations did not
statistically significantly differ among the three groups, with the possible exception of
Mexican-Americans having lower free estradiol than non-Hispanic blacks (P=0.060).
Discussion
We hypothesized that racial/ethnic variation at the time of prostate maturation could, in part,
explain the variation in US prostate cancer rates [1] among black, white, and Hispanic men,
irrespective of variation or lack of variation in hormone levels by race/ethnicity in
adulthood. However, as we previously observed in adult men (≥20 years) in NHANES III, in
males during early (12–15 years) and later (16–19 years) adolescence, testosterone
concentration was not higher in non-Hispanic blacks compared with non-Hispanic whites,
and was highest in Mexican-Americans. Unlike what we previously observed in adults,
estradiol levels were not highest in non-Hispanic blacks after multivariable adjustment.
Mexican-American males had the lowest SHBG concentration in early adolescence, but
levels did not differ among the groups in later adolescence, a pattern that differed from adult
males. The hormone patterns by race/ethnicity generally were similar when adjusting for age
and Tanner stage and after further multivariable adjustment, although the patterns were more
pronounced after this further multivariable adjustment.
We identified seven studies (in addition to our own) that have investigated black and white
differences in sex steroid hormone levels in adolescent males (Table 4); one did not test for
statistical differences by race in males [28]. For testosterone, our findings are consistent with
the studies by Hill et al. (adolescents) [14], Srinivasan et al. (adolescents) [15], Richards et
al. (children and adolescents) [16], and Morrison et al. (children and adolescents) [22],
which did not find statistically significant differences in total or free testosterone in male
children and adolescents. The exceptions were the studies by Winters et al. (young adults)
[21] and Ross et al. (young adults) [20], who reported statistically significantly higher
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testosterone in 18–24 year old black than white males. For estradiol, our results are possibly
consistent with those of Winters et al. (young adults) [21], which also did not find
statistically significant differences in estradiol levels by race. In contrast, Hill et al.
(adolescents) [14], Srinivasan et al. (adolescents) [15], Richards et al. (children and
adolescents) [16], and Morrison et al. (children and adolescents) [22] reported higher levels
in blacks than whites. For SHBG, our findings differ from those of Winters et al. (young
adults) [21]. Differences among the studies are likely, in part, due to the inclusion of
differing age ranges and differing extents of adjustment for age, puberty stage, and other
factors that influence hormone and SHBG levels.
Variation in sex steroid hormones comparing adolescent Mexican-American males to other
racial/ethnic groups has not been investigated other than in NHANES III. After our original
publication on racial/ethnic variation in hormone concentrations in men [3], Mazur
reanalyzed the data to further assess influential factors [29]. Although we had measured
hormone levels in adolescents, we did not include them in our first paper to be able to
address in greater detail the influence of puberty status later. Mazur included both adults and
adolescents in his paper and reported no association between being black or Mexican-
American and testosterone or SHBG concentration in the adolescent males when taking into
account age, pubic hair development, BMI and triceps skinfold. Unlike Mazur, in our
current paper, we used sampling weights to account for the oversampling of non-Hispanic
blacks and Mexican-Americans, among other groups, as indicated by the National Center for
Health Statistics [23]. We also adjusted for a different set of factors with possible influence
on circulating hormone concentrations. The differences we observed for total and free
testosterone (higher), total estradiol (lower), and SHBG (lower) between Mexican-American
adolescents and the other two racial/ethnic groups require further investigation in other
studies.
Several aspects of our study merit discussion. Although our sample size was small, the
adolescent males were sampled from the US population to be nationally representative. We
included adolescents who are Mexican-American, the most common group of Hispanics at
the time of NHANES III [32]; whether their results would apply to Hispanics of other
countries of origin is unknown. Because US racial and ethnic groups are known to enter into
puberty at different ages on average [30, 31], and because testosterone rises steeply in
puberty in males, we adjusted for both age and Tanner stage. Furthermore, because US
racial/ethnic groups tend to vary in their body fat composition and distribution, and body fat
influences hormone levels, we adjusted for measures of total and central body fat. However,
the approach we used to estimate percent body fat [24] was not available for Mexican-
American adolescents; we used the method available for whites with the assumption that the
accuracy of the estimate was comparable.
Although it has been hypothesized that high prostate cancer risk among black men can be
attributed to higher testosterone levels, our previous findings in men and current findings in
adolescent males in NHANES III do not the support this hypothesis. We presented age and
Tanner stage-adjusted results and results after further multivariable adjustment. We used
both adjustment strategies because they lead to difference inferences. The former results
provide a sense of the racial/ethnic patterns in hormones levels at the same point during
puberty in the US population. As such, any racial/ethnic variation in these hormone levels,
in theory, could explain the racial/ethnic patterns of prostate cancer risk seen in the US
population. However, again, we did not find possibly explanatory patterns for testosterone.
The latter results provide a sense of whether there are remaining racial/ethnic patterns in
hormones levels beyond those due to modifiable factors that are already known to influence
hormone levels and that vary by race/ethnicity, such as the extent of body fatness. In the
multivariable-adjusted analysis, we also mutually adjusted testosterone, estradiol, and
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SHBG (and separately free testosterone and free estradiol) to be able to isolate the
associations for these correlated hormones and to report on bioavailable hormones levels.
The results from this multivariable-adjusted analysis allow us to consider the following: 1)
whether intervening on the modifiable factors would create more similar racial/ethnic
patterns in hormone levels, and thus, in theory, reduce the racial/ethnic disparity in prostate
cancer incidence and mortality, or 2) whether the patterns may reflect inherent racial/ethnic
differences in hormone levels, and thus, the disparity in prostate cancer burden must be
addressed through secondary and tertiary prevention strategies. Again, we did not find
possibly explanatory patterns in non-Hispanic black versus non-Hispanic white men for
testosterone. We noted more pronounced racial/ethnic differences in testosterone levels,
which were driven by higher levels in Mexican-Americans, after multivariable adjustment.
At this time we cannot determine if these patterns truly reflect inherent racial differences or
whether we have not sufficiently taken into account those factors that influence testosterone
levels and that differ by race/ethnicity.
We should also note that the adolescents (recruited in the late 1980s/early 1990s) we studied
have not yet reached the age range for prostate cancer risk. So, it is unclear whether these
adolescents in the future, when they reach mid- and older adulthood, would experience the
same racial/ethnic disparities in prostate cancer as the men being diagnosed with the disease
now. Further, in this cross-sectional study, we did not study prostate cancer as the outcome,
so we cannot determine whether the small racial/ethnic differences we observed in hormone
levels at the time of prostate maturation influence prostate cancer risk. Finally, we could not
address whether racial/ethnic variation in the cumulative exposure to adult-level hormones
(i.e., non-Hispanic black males enter puberty earlier), rather than hormone levels per se,
might explain the racial/ethnic disparity in prostate cancer rates. A large multiracial/ethnic,
long-term prospective study with biospecimens would be required to evaluate whether
racial/ethnic variation in hormone levels in adolescence and/or the cumulative exposure to
adult hormone levels starting in adolescence explains the racial/ethnic disparity in prostate
cancer rates.
In summary, our previous findings in men and current findings in male adolescents do not
the support the hypothesis that the higher prostate cancer rate in black men compared to men
of other racial/ethnic groups is due to higher testosterone levels at the time of prostate
maturation in adolescence or in adulthood. However, our findings do lead to the question of
why Mexican-American adolescents and adults have higher testosterone concentrations than
non-Hispanic whites and non-Hispanic blacks and whether this difference influences their
lower risk of prostate cancer later in life.
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